Previous Page  2 / 4 Next Page
Information
Show Menu
Previous Page 2 / 4 Next Page
Page Background

Page 63

conferenceseries

.com

Volume 7

Journal of Hypertension: Open Access

ISSN: 2167-1095

Hypertension 2018

September 10-11, 2018

September 10-11, 2018 | Zurich, Switzerland

4

th

International Conference on

Hypertension & Healthcare

The relationship betweenMTHFRC677T gene polymorphism and essential hypertension in a sample

of an Algerian population of the Oran city

Asma Amrani-Midoun

1

, Soto Romuald Kiando

2,3

, Cyrielle Treard

2,3

, Xavier Jeunemaitre

2,3,4

and

Nabila Bouatia-Naji

2,3

1

University of Oran, Algeria

2

INSERM, France

3

Paris-Descartes University, France

4

AP-HP, France

Background:

Many studies have investigated the role of 5, 10-methylenetetrahydrofolate reductase(MTHFR) C677T gene

polymorphism in essential hypertension (EH), but with conflicting results.

Aim:

To determine the eventual association between 5,10-methylenetetrahydrofolate reductase(MTHFR) C677T gene

polymorphism and hypertension in a sample of Algerian population from the Oran city.

Methods:

A case-control study has been performed in 154 subjects including 82 hypertensives defined as subjects with elevated

systolic blood pressure SBD≥140mmHg and or sustained diastolic blood pressure DBP≥90mmHg, and 72 normotensive

subjects. Polymerase chain reaction (PCR) combined with restrictive fragment length polymorphism (RFLP) was used to

detect the MTHFR C677T variant.

Results:

We observe no significant differences between allelic and genotypic frequencies between cases and controls for C677T

polymorphism (OR=1.51, 95% CI= 0.89-2.56, P=0.13). Analyses adjusted for age, sex and body mass index improved the

association level, though the association was still not significant (30% vs. 22%, OR=1.75, 95% CI= 0.95-3.24, P=0.07).

Conclusion:

This work showed that genetic polymorphism related to the MTHFR gene (C677T) is not associated with the risk

of hypertension in this sample of Algerian population. Larger case- control samples are required to clearly assess the role of

this genetic variant in EH.

dr.asma.amrani@gmail.com

J Hypertens (Los Angel) 2018, Volume 7

DOI: 10.4172/2167-1095-C1-006